| Title |
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions
|
|---|---|
| Published in |
PharmacoEconomics, March 2019
|
| DOI | 10.1007/s40273-019-00788-3 |
| Pubmed ID | |
| Authors |
Pei-Jung Lin, Brittany D’Cruz, Ashley A. Leech, Peter J. Neumann, Myrlene Sanon Aigbogun, Dorothee Oberdhan, Tara A. Lavelle |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 73% |
| Australia | 1 | 9% |
| New Zealand | 1 | 9% |
| Unknown | 1 | 9% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 5 | 45% |
| Members of the public | 5 | 45% |
| Science communicators (journalists, bloggers, editors) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 87 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 12 | 14% |
| Researcher | 10 | 11% |
| Student > Master | 9 | 10% |
| Student > Bachelor | 8 | 9% |
| Other | 5 | 6% |
| Other | 8 | 9% |
| Unknown | 35 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 12 | 14% |
| Medicine and Dentistry | 10 | 11% |
| Economics, Econometrics and Finance | 8 | 9% |
| Psychology | 6 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
| Other | 8 | 9% |
| Unknown | 38 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2022.
All research outputs
#2,195,941
of 25,175,727 outputs
Outputs from PharmacoEconomics
#157
of 1,984 outputs
Outputs of similar age
#47,786
of 357,742 outputs
Outputs of similar age from PharmacoEconomics
#5
of 39 outputs
Altmetric has tracked 25,175,727 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,984 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 357,742 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.